Engineered molecules

Our bespoke, iterative approach to radiotherapeutic design is fueled by a toolbox of technologies for peptide-based radiopharmaceuticals.

Our pipeline

We are developing a robust pipeline of radiopharmaceuticals to address targets spanning solid and hematologic malignancies.

Industry-leading team

Backed by top-tier investors, our team has decades of expertise developing radiopharmaceuticals for highly targeted treatment of cancer.

News & Events